← back to search

Shoa L. Clarke

Stanford University · US
Area of research
Genetics · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Genetic Associations and Epidemiology, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health, and Genetic Mapping and Diversity in Plants and Animals.
h-index
17
citations
2,666
works
76
NIH funding
primary concept
Medicine
email

Recent publications

CXCL12 drives natural variation in coronary artery anatomy across diverse populations
Cell 2025cited by 10position: middledoi
Polygenic risk score for type 2 diabetes shows context-dependent effects across populations
Nature Communications 2025cited by 4position: middledoi
Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization
Circulation Genomic and Precision Medicine 2024cited by 32position: middledoi
Rare variant contribution to the heritability of coronary artery disease
Nature Communications 2024cited by 13position: middledoi
Abstract 1106: A Plasma Proteomic Signature For Atherosclerotic Cardiovascular Disease Risk Prediction In The UK Biobank
Arteriosclerosis Thrombosis and Vascular Biology 2024cited by 1position: middledoi
Abstract 4113475: Association of Age at Diabetes Diagnosis and All-cause and Cardiovascular Mortality among 600,000 US Adults
Circulation 2024cited by 1position: middledoi
PLASMA PROTEOMICS AND VISCERAL ADIPOSE TISSUE VOLUME: A MACHINE LEARNING ANALYSIS OF INTERACTION BETWEEN BIOMARKERS, SOCIO-BEHAVIORAL, AND FITNESS FACTORS IN UK BIOBANK
Journal of the American College of Cardiology 2024cited by 0position: middledoi
7515 Plasma proteomic signatures for type 2 diabetes mellitus and related traits in the UK Biobank
Journal of the Endocrine Society 2024cited by 0position: middledoi
A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease
Nature Medicine 2023cited by 244position: middledoi
A genetically supported drug repurposing pipeline for diabetes treatment using electronic health records
EBioMedicine 2023cited by 23position: middledoi
Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification
Nature Cardiovascular Research 2023cited by 17position: middledoi
Author Correction: The power of genetic diversity in genome-wide association studies of lipids
Nature 2023cited by 14position: middledoi
A Multi-Ancestry Polygenic Risk Score for Coronary Heart Disease Based on an Ancestrally Diverse Genome-Wide Association Study and Population-Specific Optimization
medRxiv 2023cited by 8position: middledoi
Polygenic score informed by genome-wide association studies of multiple ancestries and related traits improves risk prediction for coronary artery disease
medRxiv 2023cited by 3position: middledoi
Large-scale genome-wide association study of coronary artery disease in genetically diverse populations
Nature Medicine 2022cited by 339position: middledoi
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
Science Advances 2022cited by 89position: middledoi
Confounders mediate AI prediction of demographics in medical imaging
npj Digital Medicine 2022cited by 46position: middledoi
Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management
EBioMedicine 2022cited by 21position: middledoi
Abstract 14453: Deep Learning Enabled Measurement of Cardiac Sphericity Predicts Disease Risk Among Subjects With Normal Left Ventricular Size and Function
Circulation 2022cited by 0position: lastdoi
The power of genetic diversity in genome-wide association studies of lipids
Nature 2021cited by 1,033position: middledoi
Abstract 13771: Combining Clinical and Polygenic Risk Improves Stroke Prediction Among Individuals With Atrial Fibrillation
Circulation 2020cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Themistocles L. Assimes · Stanford University8 papers (2023–2024)Philip S. Tsao · Stanford University6 papers (2023–2024)Catherine Tcheandjieu · Kaiser Permanente5 papers (2020–2024)Julie A. Lynch · University of Utah4 papers (2022–2024)Trisha Gupte · Palo Alto University3 papers (2024–2024)Kevin Nzenkue · Palo Alto University3 papers (2024–2024)Ming‐Li Chen · Stanford University3 papers (2024–2024)Fahim Abbasi · Palo Alto University3 papers (2024–2024)Jiayan Zhou · Palo Alto University3 papers (2024–2024)Daniel J. Panyard · Palo Alto University3 papers (2024–2024)Zahra Azizi · Palo Alto University3 papers (2024–2024)Pik Fang Kho · Palo Alto University3 papers (2024–2024)Rodrigo Guarischi‐Sousa · Palo Alto University3 papers (2024–2024)David Ouyang · Kaiser Permanente2 papers (2022–2022)Ozan Dikilitas · Mayo Clinic in Arizona2 papers (2023–2024)Austin T. Hilliard · Stanford University2 papers (2023–2024)Yii‐Der Ida Chen · Harvard University2 papers (2023–2024)Kent Heberer · VA Palo Alto Health Care System2 papers (2022–2023) · 2 papers (2022–2023)Adam S. Butterworth · University of Cambridge2 papers (2023–2023)